Vanguard Global Advisers’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
Vanguard Global Advisers's LMAT Position: Q3 2026 in Review
Vanguard Global Advisers increased its LeMaitre Vascular (LMAT) stake by 1.3% in Q3 2026, buying an estimated $9.39K and bringing the position to 8,109 shares worth $670K. The position accounts for ﹤0.01% of the portfolio, ranked #1950.
Vanguard Global Advisers first reported a position in LMAT in Q1 2026 and has held it in 3 quarters since. The position peaked at $924K in Q1 2026. 298 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.
- Vanguard Global Advisers held 8,109 shares of LeMaitre Vascular worth $670K as of Q3 2026.
- Vanguard Global Advisers bought 106 LeMaitre Vascular shares in Q3 2026, an estimated $9.39K.
- LeMaitre Vascular made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1950 holding.
- Vanguard Global Advisers first reported a position in LeMaitre Vascular in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's LeMaitre Vascular position peaked at $924K in Q1 2026.
- 298 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.